ArticleFrontiers in oncology2025

TAS-102 in combination with bevacizumab for second-line treatment of metastatic colorectal cancer with a hypertensive elderly patient: a case report.

Lingling Xu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.